Consolidated Statement of Stockholders' Deficiency Equity (Unaudited) - 3 months ended Mar. 31, 2020 - USD ($)	Series C Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2019	$ 10	$ 716,617	$ 28,719,246	$ (57,837,687)	$ (28,401,814)
Balance, shares at Dec. 31, 2019	10,434	71,661,656
Net loss				(928,346)	(928,346)
Balance at Mar. 31, 2020	$ 10	$ 716,617	$ 28,719,246	$ (58,766,033)	$ (29,330,160)
Balance, shares at Mar. 31, 2020	10,434	71,661,656